| __timestamp | Soleno Therapeutics, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 72471000 |
| Thursday, January 1, 2015 | 7878291 | 89204000 |
| Friday, January 1, 2016 | 8366794 | 106010000 |
| Sunday, January 1, 2017 | 6610381 | 137905000 |
| Monday, January 1, 2018 | 6556000 | 159888000 |
| Tuesday, January 1, 2019 | 6930000 | 158425000 |
| Wednesday, January 1, 2020 | 8758000 | 200677000 |
| Friday, January 1, 2021 | 10806000 | 304759000 |
| Saturday, January 1, 2022 | 9844000 | 377221000 |
| Sunday, January 1, 2023 | 13481000 | 336361000 |
Unleashing insights
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Supernus Pharmaceuticals, Inc. and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to SG&A efficiency. From 2014 to 2023, Supernus Pharmaceuticals consistently outspent Soleno Therapeutics, with SG&A expenses peaking at approximately $336 million in 2023, a staggering 2,400% higher than Soleno's $13 million. This disparity highlights Supernus's aggressive investment in administrative and sales functions, potentially fueling its growth and market presence. Meanwhile, Soleno's leaner approach may reflect a strategic focus on cost control, possibly due to its smaller scale or different market strategy. Understanding these trends offers valuable insights into how biopharma companies allocate resources to drive innovation and market success.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Soleno Therapeutics, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
CRISPR Therapeutics AG or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Supernus Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.